These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24967412)

  • 1. EMMPRIN expression in oral squamous cell carcinomas: correlation with tumor proliferation and patient survival.
    Monteiro LS; Delgado ML; Ricardo S; Garcez F; do Amaral B; Pacheco JJ; Lopes C; Bousbaa H
    Biomed Res Int; 2014; 2014():905680. PubMed ID: 24967412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EMMPRIN/BASIGIN as a biological modulator of oral cancer and COVID-19 interaction: Novel propositions.
    Varadarajan S; Balaji TM; Sarode SC; Sarode GS; Sharma NK; Gondivkar S; Gadbail A; Patil S
    Med Hypotheses; 2020 Oct; 143():110089. PubMed ID: 32673940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surrogate Prognostic Biomarkers in OSCC: The Paradigm of PA28γ Overexpression.
    Kontos CK
    EBioMedicine; 2015 Aug; 2(8):784-5. PubMed ID: 26425675
    [No Abstract]   [Full Text] [Related]  

  • 4. Co-Expression of TWIST1 and ZEB2 in Oral Squamous Cell Carcinoma Is Associated with Poor Survival.
    Kong YH; Syed Zanaruddin SN; Lau SH; Ramanathan A; Kallarakkal TG; Vincent-Chong VK; Wan Mustafa WM; Abraham MT; Abdul Rahman ZA; Zain RB; Cheong SC
    PLoS One; 2015; 10(7):e0134045. PubMed ID: 26214683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression.
    Lescaille G; Menashi S; Cavelier-Balloy B; Khayati F; Quemener C; Podgorniak MP; Naïmi B; Calvo F; Lebbe C; Mourah S
    BMC Cancer; 2012 Mar; 12():115. PubMed ID: 22443116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular matrix metalloproteinase inducer expression in histological grades of oral squamous cell carcinoma - An immunohistochemical study.
    Khan SM; Prakash N; Pradeep GL; Mahajan A; Mokashi RR; Patil R
    J Oral Maxillofac Pathol; 2020; 24(3):530-535. PubMed ID: 33967492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downexpression of Matriptase-2 Correlates With Tumor Progression and Clinical Prognosis in Oral Squamous-Cell Carcinoma.
    Cheng MF; Lin LH; Huang MS; Lee HS; Ji DD; Lin CS; Hsia KT
    Appl Immunohistochem Mol Morphol; 2017 Aug; 25(7):481-488. PubMed ID: 26862950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular localization of EMMPRIN predicts prognosis of patients with operable lung adenocarcinoma independent from MMP-2 and MMP-9.
    Sienel W; Polzer B; Elshawi K; Lindner M; Morresi-Hauf A; Vay C; Eder F; Passlick B; Klein CA
    Mod Pathol; 2008 Sep; 21(9):1130-8. PubMed ID: 18567995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
    Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different patterns of expression of cell cycle control and local invasion-related proteins in oral squamous cell carcinoma affecting young patients.
    Miranda Galvis M; Santos-Silva AR; Freitas Jardim J; Paiva Fonseca F; Lopes MA; de Almeida OP; Lópes Pinto CA; Kaminagakura E; Sawazaki-Calone I; Speight PM; Kowalski LP
    J Oral Pathol Med; 2018 Jan; 47(1):32-39. PubMed ID: 28626969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of CDK7 is associated with unfavourable prognosis in oral squamous cell carcinoma.
    Jiang L; Huang R; Wu Y; Diao P; Zhang W; Li J; Li Z; Wang Y; Cheng J; Yang J
    Pathology; 2019 Jan; 51(1):74-80. PubMed ID: 30473182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of FAM3C is associated with poor prognosis in oral squamous cell carcinoma.
    Wu CC; Xiao Y; Li H; Mao L; Deng WW; Yu GT; Zhang WF; Sun ZJ
    Pathol Res Pract; 2019 Apr; 215(4):772-778. PubMed ID: 30683473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of matrix metalloproteinase 2 and extracellular matrix metalloproteinase inducer are unfavorable postoperative prognostic factors in intrahepatic cholangiocarcinoma.
    Zhang C; Tu Z; Du S; Wang Y; Wang Q
    Pathol Oncol Res; 2010 Mar; 16(1):47-53. PubMed ID: 19629755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of podoplanin expression in oral squamous cell carcinoma--a regression model auxiliary to UICC classification.
    Seki S; Fujiwara M; Matsuura M; Fujita S; Ikeda H; Umeda M; Asahina I; Ikeda T
    Pathol Oncol Res; 2014 Jul; 20(3):521-8. PubMed ID: 24281769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of T-lymphoma invasion and metastasis factor on the occurrence of oral squamous cell carcinoma.
    Song B; Wang LF; Fan XH; Zuo JH; Huang YM
    J Biol Regul Homeost Agents; 2017; 31(2):289-295. PubMed ID: 28685528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly expressed tumoral emmprin and stromal CD73 predict a poor prognosis for external auditory canal carcinoma.
    Miyazaki M; Aoki M; Okado Y; Koga K; Hamasaki M; Nakagawa T; Sakata T; Nabeshima K
    Cancer Sci; 2020 Aug; 111(8):3045-3056. PubMed ID: 32473077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of histamine H1 receptor expression in oral squamous cell carcinoma.
    Grimm M; Krimmel M; Alexander D; Munz A; Kluba S; Keutel C; Hoffmann J; Polligkeit J; Reinert S; Hoefert S
    Clin Oral Investig; 2013 Apr; 17(3):949-55. PubMed ID: 22782258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
    Kang Y; Zhang Y; Sun Y
    Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined cytoplasmic and membranous EGFR and p53 overexpression is a poor prognostic marker in early stage oral squamous cell carcinoma.
    Monteiro LS; Diniz-Freitas M; Garcia-Caballero T; Warnakulasuriya S; Forteza J; Fraga M
    J Oral Pathol Med; 2012 Aug; 41(7):559-67. PubMed ID: 22417132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
    Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
    Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.